1,480
Views
2
CrossRef citations to date
0
Altmetric
Coronaviruses

Head-to-head comparisons of the neutralizing antibody against SARS-CoV-2 variants elicited by four priming-boosting regimens

, , , , & ORCID Icon
Pages 1751-1753 | Received 09 May 2022, Accepted 24 Jun 2022, Published online: 17 Jul 2022

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Qian He, Shuying Liu, Zhenglun Liang, Shan Lu, Wei Cun & Qunying Mao. (2023) Mouse study of combined DNA/protein COVID-19 vaccine to boost high levels of antibody and cell mediated immune responses. Emerging Microbes & Infections 12:1.
Read now

Articles from other publishers (1)

Rong Tang, Hui Zheng, Bu-Sen Wang, Jin-Bo Gou, Xi-Ling Guo, Xiao-Qin Chen, Yin Chen, Shi-Po Wu, Jin Zhong, Hong-Xing Pan, Jia-Hong Zhu, Xiao-Yu Xu, Feng-Juan Shi, Zhuo-Pei Li, Jing-Xian Liu, Xiao-Yin Zhang, Lun-Biao Cui, Zhi-Zhou Song, Li-Hua Hou, Feng-Cai Zhu, Jing-Xin Li, Hai-Tao Huang, Xiao-Long Li, Xue Wang, Peng Wan & Tao Zhu. (2023) Safety and immunogenicity of aerosolised Ad5-nCoV, intramuscular Ad5-nCoV, or inactivated COVID-19 vaccine CoronaVac given as the second booster following three doses of CoronaVac: a multicentre, open-label, phase 4, randomised trial. The Lancet Respiratory Medicine 11:7, pages 613-623.
Crossref